CD4 and neoplasm: Obviously, the cell subset of anti-tumor lymphocytes including activated dendritic cells (P = 0.009), activated CD4+/CD8+ T cells (P < 0.001), and effector memory CD8 T cells (P < 0.001) were enriched in the low-risk signature group.